Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Tight hairstyles and chemical relaxers can cause hair loss known as traction alopecia.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Certain hairstyles and less hair oil use in African American girls can lead to scalp conditions like traction alopecia and seborrheic dermatitis.

Genetics and hormones cause hair loss; finasteride treats it safely.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Platelet-rich plasma, taken from a person's own blood, can help rejuvenate skin, stimulate hair growth, and treat hair loss, but more research is needed to confirm its safety and effectiveness.

Using fat-derived stem cells for hair loss treatment is safe and effective, improving hair growth and patient satisfaction.

PRP injections may improve hair thickness and density in female hair loss patients.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

HIV can cause unusual and severe skin problems that are hard to treat.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Hair loss is more common in men aged 18-49 and increases with age.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Face-lifts can lead to complications like bleeding, nerve injury, skin death, hair loss, and rare infections, with careful surgery reducing risks.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The article concludes that advancements in hair cosmetics require dermatologists to stay informed about products and their potential risks, including allergies and higher risks for hairdressers.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

58% of men aged 30-50 have hair loss, with severity increasing with age.

Some alternative treatments for hair loss might work, but more research is needed.